Neurostimulation Devices Market Industry Analysis, Regional Data, Growth, Trends, Demand, and Forecasts 2027
Neurostimulation Devices Market Size โ USD 5.60 billion in 2019, Market Growth - CAGR of 12.6%
VANCOUER, BC, CANADA, May 19, 2022 /EINPresswire.com/ -- The Global Neurostimulation Devices Market will be worth USD 13.70 Billion by 2027, according to the latest analysis by Emergen Research. The growth of this market can be attributed to the growing incidences of health disorders due to unhealthy lifestyle habits and is expected to drive the growth of the neurostimulation devices market.
The high cost of neurostimulation devices and the presence of alternative therapeutic procedures is likely to hamper the demand for neurostimulation devices over the forecast period. Adverse effects and risks pertaining to the use of neurostimulation devices, such as allergic reactions or prickling of skin, might restrict the utilization of neurostimulation devices. Moreover, stringent government regulations on device approval might act as a barrier to the growth of the market.
๐๐จ๐ฆ๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐ Bayer AG, Johnson & Johnson, AstraZeneca PLC, Pfizer Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Amgen Inc., Merck & Co. Inc., AbbVie Inc., and Novartis AG, among others.
๐๐๐ญ ๐ ๐๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐ฐ๐ข๐ญ๐ก ๐๐๐ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ญ๐จ ๐ฎ๐ง๐๐๐ซ๐ฌ๐ญ๐๐ง๐ ๐ญ๐ก๐ ๐ฌ๐ญ๐ซ๐ฎ๐๐ญ๐ฎ๐ซ๐ ๐จ๐ ๐ญ๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ @ https://www.emergenresearch.com/request-sample-form/349
The growth of neurostimulation devices is expected to be driven by increased demand for minimally invasive surgeries due to the increasing preference among patients and doctors for faster recovery and shorter hospital stays. Demand for neurostimulation devices is most likely to be motivated by the growing prevalence of neurological disorders, such as epilepsy, dystonia and Parkinson's disease.
๐๐๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ : ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐ :
The prominent players operating in the Neurostimulation Devices Market are profiled in-depth in the report and their strategies, collaborations, and product innovations. The analysis of the key players and their strategies to fortify their presence in the market impart a better understanding of the competitive landscape of the Electronic Health Records Market.
๐๐จ๐ฆ๐ ๐๐๐ฒ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐ ๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ :
In 2019, Medtronic launched the Intellis platform for the management of certain types of chronic intractable pain. The platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the Evolve workflow. It can track patients 24/7 and help in monitoring chronic pain.
Deep brain stimulators held the second largest market share of 19.8% in 2019. The rising incidence of neurological disorders among the rising global geriatric population is expected to boost the demand for Deep brain stimulators.
Urinary and fecal Incontinence is expected to register steady growth over the forecast period. Increasing utilization of the sacral nerve stimulators for the treatment of Urinary and fecal Incontinence is expected to drive the growth of the neurostimulation devices market.
North America accounted for the largest market share of the Neurostimulation Devices market in 2019 due to the improved healthcare system and government funding for the research and development of neurostimulation devices.
๐๐๐๐๐ฌ๐ฌ ๐ญ๐ก๐ ๐๐ง๐ญ๐ข๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฉ๐๐๐ค๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐, ๐๐๐๐ฅ๐๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐ง๐ ๐๐ฎ๐ญ๐ฅ๐ข๐ง๐ ๐จ๐ ๐๐ซ๐จ๐ฆ๐ข๐ง๐๐ง๐ญ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ @ https://www.emergenresearch.com/industry-report/neurostimulation-devices-market
The Asia Pacific region is expected to be the fastest-growing region over the forecast period. The economic development and increasing Healthcare Budgetary Allocation in developing countries is expected to drive the growth of neurostimulation devices in the region.
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง :
๐๐ฆ๐๐ซ๐ ๐๐ง ๐๐๐ฌ๐๐๐ซ๐๐ก ๐ก๐๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐จ๐ง ๐ญ๐ก๐ ๐๐๐ฌ๐ข๐ฌ ๐จ๐ ๐๐ซ๐จ๐๐ฎ๐๐ญ, ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง, ๐๐ง๐ ๐ซ๐๐ ๐ข๐จ๐ง:
๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐๐๐๐-๐๐๐๐)
Sacral Nerve stimulator
Spinal Cord Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulators
Deep Brain Stimulators
๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง; ๐๐๐๐-๐๐๐๐)
Epilepsy
Depression
Dystonia
Gastroparesis
Pain management
Urinary and Fecal Incontinence
Essential Tremor
Parkinsonโs Disease
Others
๐๐๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐ง๐ ๐ซ๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง @ https://www.emergenresearch.com/request-for-customization/349
๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ข๐๐๐ฅ๐ฅ๐ฒ, ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฌ๐ญ๐ฎ๐๐ข๐๐ฌ ๐ญ๐ก๐ ๐ค๐๐ฒ ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ, ๐๐จ๐๐ฎ๐ฌ๐๐ฌ ๐จ๐ง ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ ๐ฌ๐๐ฅ๐๐ฌ, ๐ฏ๐๐ฅ๐ฎ๐, ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ก๐๐ซ๐ ๐๐ง๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐ข๐ง ๐ญ๐ก๐๐ฌ๐ ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ, ๐๐จ๐ฏ๐๐ซ๐ข๐ง๐ :
United States
Europe
China
Japan
Southeast Asia
India
๐๐ ๐๐๐ง ๐๐ฅ๐ฌ๐จ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ ๐ฌ๐๐ฉ๐๐ซ๐๐ญ๐ ๐ซ๐๐ ๐ข๐จ๐ง๐๐ฅ ๐จ๐ซ ๐๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐ฅ๐๐ฏ๐๐ฅ ๐ซ๐๐ฉ๐จ๐ซ๐ญ๐ฌ, ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ:
North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa
๐๐ก๐ฒ ๐ฌ๐ก๐จ๐ฎ๐ฅ๐ ๐ฒ๐จ๐ฎ ๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฎ๐ซ๐จ๐ฌ๐ญ๐ข๐ฆ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง ๐๐๐ฏ๐ข๐๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ซ๐๐ฉ๐จ๐ซ๐ญ?
The study paper dissects the total market potential of major regions with strengths, opportunity and challenge, constraints, and dangers.
By identifying the high-improvement locations, the study inspects the open entryways, keeping an eye out for accomplices.
It examines each submarket in terms of a single improvement design and its contribution to the market.
It examines the recent developments, such as advancements, business strategies, new product releases, and acquisitions.
It purposefully profiles the major market players and thoroughly investigates their advancement strategies.
๐๐๐ค๐ ๐ ๐๐จ๐จ๐ค ๐๐ญ ๐จ๐ฎ๐ซ ๐จ๐ญ๐ก๐๐ซ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
intelligent drug discovery market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/intelligent-drug-discovery-market
digital biomarkers market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/digital-biomarkers-market
medical devices testing services market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/medical-devices-testing-services-market
human microbiome modulators market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market
medical supplies market @ https://www.google.as/url?q=https://www.emergenresearch.com/industry-report/medical-supplies-market
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Thank you for reading our report. For further details or to inquire about customization, please let us know. We will offer you the report as per your needs.
Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn
The global Neurostimulation Devices Market will be worth USD 13.70 Billion by 2027, according to a current analysis by Emergen Research